China, India, Russia, South Africa TB Cases Spur International Coalition
This article was originally published in PharmAsia News
The growth of a drug-resistant version of tuberculosis in China, India, Russia and South Africa has spurred an international coalition of scientists to focus on a vaccine to block its spread as part of a comprehensive effort.
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.